Massachusetts · Bill 2447 · 194th General Court

An Act authorizing a 90-day supply of medically necessary testosterone therapy medication

  1. Introduced Feb 27, 2025
  2. In committee Feb 27, 2025
  3. Passed the House Next
  4. Passed the Senate  
  5. To the governor  
  6. Became law  

What it does

The legislature's own summary of the bill, or its official long title.

By Representative Higgins of Leominster, a petition (accompanied by bill, House, No. 2447) of Natalie M. Higgins, Lindsay N. Sabadosa and James B. Eldridge relative to prescriptions for testosterone therapy medications. Public Health.

Every action

8 steps, oldest first, as the legislature records them.

  1. CommitteeReferred to the committee on Public Health · Joint Committee on Public Health
  2. SenateSenate concurred
  3. CommitteeHearing scheduled for 06/11/2025 from 01:00 PM-05:00 PM in A-1 · Joint Committee on Public Health
  4. HouseReporting date extended to Thursday, October 9, 2025
  5. CommitteeReported favorably by committee and referred to the committee on Health Care Financing · Joint Committee on Health Care Financing
  6. HouseReporting date extended to Wednesday, March 18, 2026
  7. HouseReporting date extended to Monday, June 15, 2026
  8. CommitteeCommittee recommended bill ought to pass and referred to the committee on House Ways and Means · House Committee on Ways and Means

Roll calls

2 recorded votes: 0 on the floor, 2 in committee. Each shows how every member voted.

Committee votes

DateWhereQuestionResult
Oct 8, 2025 Joint Committee on Public Health Committee report: Favorable (Shall the bill be reported favorably?)
Members

Yes · 11

11–0
Apr 9, 2026 Joint Committee on Health Care Financing Committee report: Favorable (Favorable Report)
Members

Yes · 13

13–0

Sponsors

The member who introduced it, joined by 2 cosponsors: 2 Democrats.

All 2 cosponsors

From Massachusetts's official records (malegislature.gov/api), checked Nov 14, 2026. Text links go to the official versions; LegiList does not copy bill text.